Live feed
Filing
SC 13G/A
SC 13G/A0000921895-16-005673·BIOTECHNOLOGY VALUE FUND L P
Schedule 13G ownership disclosure
Xenon Pharmaceuticals Inc
Security class unavailable · CUSIP: 98420N105
Event date: 2016-09-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-16-005673
- Form type
- SC 13G/A
- Filer
- BIOTECHNOLOGY VALUE FUND L P
- CIK
- CIK 918923
- Filed
- Sep 12, 2016
- Reporting period
- Sep 08, 2016
- Description
- Schedule 13G beneficial ownership